Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anika Therapeutics (ANIK) Inventory Average (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Inventory Average for 15 consecutive years, with $17.5 million as the latest value for Q4 2025.

  • Quarterly Inventory Average fell 44.72% to $17.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.5 million through Dec 2025, down 44.72% year-over-year, with the annual reading at $21.3 million for FY2025, 11.69% down from the prior year.
  • Inventory Average for Q4 2025 was $17.5 million at Anika Therapeutics, up from $16.6 million in the prior quarter.
  • The five-year high for Inventory Average was $50.4 million in Q2 2024, with the low at $16.6 million in Q3 2025.
  • Average Inventory Average over 5 years is $35.4 million, with a median of $36.6 million recorded in 2022.
  • The sharpest move saw Inventory Average soared 37.42% in 2021, then crashed 63.55% in 2025.
  • Over 5 years, Inventory Average stood at $35.5 million in 2021, then rose by 8.41% to $38.5 million in 2022, then decreased by 11.49% to $34.1 million in 2023, then dropped by 6.92% to $31.7 million in 2024, then plummeted by 44.72% to $17.5 million in 2025.
  • According to Business Quant data, Inventory Average over the past three periods came in at $17.5 million, $16.6 million, and $19.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.